Newcastle disease virus-vectored H7 and H5 live vaccines protect chickens from challenge with H7N9 or H5N1 avian influenza viruses

Journal of Virology

Volumn 89, Issue 14, 2015, Pages 6994-7006

  Liu, Qinfang ^a,d   Mena, Ignacio ^b   Ma, Jingjiao ^a   Bawa, Bhupinder ^a   Krammer, Florian ^b   Lyoo, Young S ^a,e   Lang, Yuekun ^a   Morozov, Igor ^a   Mahardika, Gusti Ngurah ^c   Ma, Wenjun ^a   García Sastre, Adolfo ^b   Richt, Juergen A ^a  

^a KANSAS STATE UNIVERSITY   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c UDAYANA UNIVERSITY   (Indonesia)

^d INSTITUTE OF PLANT PROTECTION   (China)

^e Konkuk University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AVIAN INFLUENZA VACCINE; BACULOVIRUS VECTOR; H5 HEMAGGLUTININ PROTEIN; H7 HEMAGGLUTININ PROTEIN; NEWCASTLE DISEASE VIRUS VECTOR; UNCLASSIFIED DRUG; VIRUS HEMAGGLUTININ; VIRUS VECTOR; DRUG CARRIER; HEMAGGLUTININ, AVIAN INFLUENZA A VIRUS; INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; LIVE VACCINE; VIRUS ANTIBODY;

AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; AVIAN INFLUENZA; CLOACA; CONTROLLED STUDY; HEMAGGLUTINATION INHIBITION; IMMUNOGENICITY; INFLUENZA VIRUS A H5N1; INFLUENZA VIRUS A H7N9; NONHUMAN; OROPHARYNX; PRIORITY JOURNAL; SEROCONVERSION; SURVIVAL RATE; VIRUS SHEDDING; ANIMAL; BLOOD; CHICKEN; CHINA; GENETICS; GROWTH, DEVELOPMENT AND AGING; HEMAGGLUTINATION INHIBITION TEST; IMMUNOLOGY; INFLUENZA A VIRUS (H5N1); INFLUENZA A VIRUS (H7N9); INFLUENZA IN BIRDS; NEWCASTLE DISEASE VIRUS; SURVIVAL;

AVIAN INFLUENZA VIRUS; GALLUS GALLUS; NEWCASTLE DISEASE VIRUS;

ANIMALS; ANTIBODIES, VIRAL; CHICKENS; CHINA; DRUG CARRIERS; HEMAGGLUTINATION INHIBITION TESTS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA A VIRUS, H7N9 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA VACCINES; NEWCASTLE DISEASE VIRUS; SURVIVAL ANALYSIS; VACCINES, ATTENUATED;

EID: 84931035985     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00031-15     Document Type: Article

References (27)

1. Zhou J, Wang D, Gao R, Zhao B, Song J, Qi X, Zhang Y, Shi Y, Yang L, Zhu W, Bai T, Qin K, Lan Y, Zou S, Guo J, Dong J, Dong L, Zhang Y, Wei H, Li X, Lu J, Liu L, Zhao X, Li X, Huang W, Wen L, Bo H, Xin L, Chen Y, Xu C, Pei Y, Yang Y, Zhang X, Wang S, Feng Z, Han J, Yang W, Gao GF, Wu G, Li D, Wang Y, Shu Y. 2013. Biological features of novel avian influenza A (H7N9) virus. Nature 499:500-503. http://dx.doi.org/10.1038/nature12379.
2. Richard M, Schrauwen EJ, de Graaf M, Bestebroer TM, Spronken MI, van Boheemen S, de Meulder D, Lexmond P, Linster M, Herfst S, Smith DJ, van den Brand JM, Burke DF, Kuiken T, Rimmelzwaan GF, Osterhaus AD, Fouchier RA. 2013. Limited airborne transmission of H7N9 influenza A virus between ferrets. Nature 501:560-563. http://dx.doi.org/10.1038/nature12476.
3. To KK, Chan JF, Chen H, Li L, Yuen KY. 2013. The emergence of influenza A H7N9 in human beings 16 years after influenza A H5N1: a tale of two cities. Lancet Infect Dis 13:809-821. http://dx.doi.org/10.1016/S1473-3099(13)70167-1.
4. Lam TT, Wang J, Shen Y, Zhou B, Duan L, Cheung CL, Ma C, Lycett SJ, Leung CY, Chen X, Li L, Hong W, Chai Y, Zhou L, Liang H, Ou Z, Liu Y, Farooqui A, Kelvin DJ, Poon LL, Smith DK, Pybus OG, Leung GM, Shu Y, Webster RG, Webby RJ, Peiris JS, Rambaut A, Zhu H, Guan Y. 2013. The genesis and source of the H7N9 influenza viruses causing human infections in China. Nature 502:241-244. http://dx.doi.org/10.1038/nature12515.
5. Zhu H, Wang D, Kelvin DJ, Li L, Zheng Z, Yoon SW, Wong SS, Farooqui A, Wang J, Banner D, Chen R, Zheng R, Zhou J, Zhang Y, Hong W, Dong W, Cai Q, Roehrl MH, Huang SS, Kelvin AA, Yao T, Zhou B, Chen X, Leung GM, Poon LL, Webster RG, Webby RJ, Peiris JS, Guan Y, Shu Y. 2013. Infectivity, transmission, and pathology of human-isolated H7N9 influenza virus in ferrets and pigs. Science 341: 183-186. http://dx.doi.org/10.1126/science.1239844.
6. Margine I, Palese P, Krammer F. 2013. Expression of functional recombinant hemagglutinin and neuraminidase proteins from the novel H7N9 influenza virus using the baculovirus expression system. J Vis Exp 2013(81):e51112. http://dx.doi.org/10.3791/51112.
7. Ge J, Deng G, Wen Z, Tian G, Wang Y, Shi J, Wang X, Li Y, Hu S, Jiang Y, Yang C, Yu K, Bu Z, Chen H. 2007. Newcastle disease virus-based live attenuated vaccine completely protects chickens and mice from lethal challenge of homologous and heterologous H5N1 avian influenza viruses. J Virol 81:150-158. http://dx.doi.org/10.1128/JVI.01514-06.
8. Mao H, Yen HL, Liu Y, Lau YL, Malik Peiris JS, Tu W. 2014. Conservation of T cell epitopes between seasonal influenza viruses and the novel influenza A H7N9 virus. Virol Sin 29:170-175. http://dx.doi.org/10.1007/s12250-014-3473-3.
9. De Groot AS, Ardito M, Terry F, Levitz L, Ross T, Moise L, Martin W. 2013. Low immunogenicity predicted for emerging avian-origin H7N9: implication for influenza vaccine design. Hum Vaccin Immunother 9:950-956. http://dx.doi.org/10.4161/hv.24939.
10. De Groot AS, Moise L, Liu R, Gutierrez AH, Terry F, Koita OA, Ross TM, Martin W. 2014. Cross-conservation of T-cell epitopes: now even more relevant to (H7N9) influenza vaccine design. Hum Vaccin Immunother 10:256-262. http://dx.doi.org/10.4161/hv.28135.
11. Rudenko L, Isakova-Sivak I, Donina S. 2013. H7N3 live attenuated influenza vaccine has a potential to protect against new H7N9 avian influenza virus. Vaccine 31:4702-4705. http://dx.doi.org/10.1016/j.vaccine.2013.08.040.
12. Rudenko L, Isakova-Sivak I, Rekstin A. 2014. H7N9: can H7N3 liveattenuated influenza vaccine be used at the early stage of the pandemic? Expert Rev Vaccines 13:1-4. http://dx.doi.org/10.1586/14760584.2014.864564.
13. Xu Q, Chen Z, Cheng X, Xu L, Jin H. 2013. Evaluation of live attenuated H7N3 and H7N7 vaccine viruses for their receptor binding preferences, immunogenicity in ferrets and cross reactivity to the novel H7N9 virus. PLoS One 8:e76884. http://dx.doi.org/10.1371/journal.pone.0076884.
14. Goff PH, Krammer F, Hai R, Seibert CW, Margine I, Garcia-Sastre A, Palese P. 2013. Induction of cross-reactive antibodies to novel H7N9 influenza virus by recombinant Newcastle disease virus expressing a North American lineage H7 subtype hemagglutinin. J Virol 87:8235-8240. http://dx.doi.org/10.1128/JVI.01085-13.
15. Klausberger M, Wilde M, Palmberger D, Hai R, Albrecht RA, Margine I, Hirsh A, Garcia-Sastre A, Grabherr R, Krammer F. 2014. One-shot vaccination with an insect cell-derived low-dose influenza A H7 virus-like particle preparation protects mice against H7N9 challenge. Vaccine 32: 355-362. http://dx.doi.org/10.1016/j.vaccine.2013.11.036.
16. Krammer F, Albrecht RA, Tan GS, Margine I, Hai R, Schmolke M, Runstadler J, Andrews SF, Wilson PC, Cox RJ, Treanor JJ, Garcia-Sastre A, Palese P. 2014. Divergent H7 immunogens offer protection from H7N9 virus challenge. J Virol 88:3976-3985. http://dx.doi.org/10.1128/JVI.03095-13.
17. Krammer F, Margine I, Hai R, Flood A, Hirsh A, Tsvetnitsky V, Chen D, Palese P. 2014. H3 stalk-based chimeric hemagglutinin influenza virus constructs protect mice from H7N9 challenge. J Virol 88:2340-2343. http://dx.doi.org/10.1128/JVI.03183-13.
18. Smith GE, Flyer DC, Raghunandan R, Liu Y, Wei Z, Wu Y, Kpamegan E, Courbron D, Fries LF, III, Glenn GM. 2013. Development of influenza H7N9 virus like particle (VLP) vaccine: homologous A/Anhui/1/2013 (H7N9) protection and heterologous A/chicken/Jalisco/CPA1/2012 (H7N3) cross-protection in vaccinated mice challenged with H7N9 virus. Vaccine 31:4305-4313. http://dx.doi.org/10.1016/j.vaccine.2013.07.043.
19. Nakaya T, Cros J, Park MS, Nakaya Y, Zheng H, Sagrera A, Villar E, Garcia-Sastre A, Palese P. 2001. Recombinant Newcastle disease virus as a vaccine vector. J Virol 75:11868-11873. http://dx.doi.org/10.1128/JVI.75.23.11868-11873.2001.
20. Park MS, Steel J, Garcia-Sastre A, Swayne D, Palese P. 2006. Engineered viral vaccine constructs with dual specificity: avian influenza and Newcastle disease. Proc Natl Acad Sci USA 103:8203-8208. http://dx.doi.org/10.1073/pnas.0602566103.
21. DiNapoli JM, Nayak B, Yang L, Finneyfrock BW, Cook A, Andersen H, Torres-Velez F, Murphy BR, Samal SK, Collins PL, Bukreyev A. 2010. Newcastle disease virus-vectored vaccines expressing the hemagglutinin or neuraminidase protein of H5N1 highly pathogenic avian influenza virus protect against virus challenge in monkeys. J Virol 84:1489-1503. http://dx.doi.org/10.1128/JVI.01946-09.
22. DiNapoli JM, Yang L, Suguitan A, Jr, Elankumaran S, Dorward DW, Murphy BR, Samal SK, Collins PL, Bukreyev A. 2007. Immunization of primates with a Newcastle disease virus-vectored vaccine via the respiratory tract induces a high titer of serum neutralizing antibodies against highly pathogenic avian influenza virus. J Virol 81:11560-11568. http://dx.doi.org/10.1128/JVI.00713-07.
23. Ge J, Wang X, Tao L, Wen Z, Feng N, Yang S, Xia X, Yang C, Chen H, Bu Z. 2011. Newcastle disease virus-vectored rabies vaccine is safe, highly immunogenic, and provides long-lasting protection in dogs and cats. J Virol 85:8241-8252. http://dx.doi.org/10.1128/JVI.00519-11.
24. Kong D, Wen Z, Su H, Ge J, Chen W, Wang X, Wu C, Yang C, Chen H, Bu Z. 2012. Newcastle disease virus-vectored Nipah encephalitis vaccines induceBandTcell responses in mice and long-lasting neutralizing antibodies in pigs. Virology 432:327-335. http://dx.doi.org/10.1016/j.virol.2012.06.001.
25. Lee DH, Park JK, Kwon JH, Yuk SS, Erdene-Ochir TO, Jang YH, Seong BL, Lee JB, Park SY, Choi IS, Song CS. 2013. Efficacy of single dose of a bivalent vaccine containing inactivated Newcastle disease virus and reassortant highly pathogenic avian influenza H5N1 virus against lethal HPAI and NDV infection in chickens. PLoS One 8:e58186. http://dx.doi.org/10.1371/journal.pone.0058186.
26. Nayak B, Rout SN, Kumar S, Khalil MS, Fouda MM, Ahmed LE, Earhart KC, Perez DR, Collins PL, Samal SK. 2009. Immunization of chickens with Newcastle disease virus expressing H5 hemagglutinin protects against highly pathogenic H5N1 avian influenza viruses. PLoS One 4:e6509. http://dx.doi.org/10.1371/journal.pone.0006509.
27. Zhao W, Spatz S, Zhang Z, Wen G, Garcia M, Zsak L, Yu Q. 2014. Newcastle disease virus (NDV) recombinants expressing infectious laryngotracheitis virus (ILTV) glycoproteins gB and gD protect chickens against ILTV and NDV challenges. J Virol 88:8397-8406. http://dx.doi.org/10.1128/JVI.01321-14.